The specific concentrations of lincomycin in non-target feed for food-producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. However, due to the lack of data on the parameters required to calculate the FARSC, it was not possible to conclude the assessment until further experimental data become available. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels of lincomycin in feed that showed to have an effect on growth promotion/increased yield were reported. It was recommended to carry out studies to generate the data that are required to fill the gaps which prevented the calculation of the FARSC for lincomycin.

Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 5: Lincosamides: lincomycin / Koutsoumanis K.; Allende A.; Alvarez-Ordonez A.; Bolton D.; Bover-Cid S.; Chemaly M.; Davies R.; De Cesare A.; Herman L.; Hilbert F.; Lindqvist R.; Nauta M.; Ru G.; Simmons M.; Skandamis P.; Suffredini E.; Andersson D.I.; Bampidis V.; Bengtsson-Palme J.; Bouchard D.; Ferran A.; Kouba M.; Lopez Puente S.; Lopez-Alonso M.; Nielsen S.S.; Pechova A.; Petkova M.; Girault S.; Broglia A.; Guerra B.; Innocenti M.L.; Liebana E.; Lopez-Galvez G.; Manini P.; Stella P.; Peixe L.. - In: EFSA JOURNAL. - ISSN 1831-4732. - ELETTRONICO. - 19:10(2021), pp. e06856.1-e06856.22. [10.2903/j.efsa.2021.6856]

Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 5: Lincosamides: lincomycin

De Cesare A.;
2021

Abstract

The specific concentrations of lincomycin in non-target feed for food-producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. However, due to the lack of data on the parameters required to calculate the FARSC, it was not possible to conclude the assessment until further experimental data become available. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels of lincomycin in feed that showed to have an effect on growth promotion/increased yield were reported. It was recommended to carry out studies to generate the data that are required to fill the gaps which prevented the calculation of the FARSC for lincomycin.
2021
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 5: Lincosamides: lincomycin / Koutsoumanis K.; Allende A.; Alvarez-Ordonez A.; Bolton D.; Bover-Cid S.; Chemaly M.; Davies R.; De Cesare A.; Herman L.; Hilbert F.; Lindqvist R.; Nauta M.; Ru G.; Simmons M.; Skandamis P.; Suffredini E.; Andersson D.I.; Bampidis V.; Bengtsson-Palme J.; Bouchard D.; Ferran A.; Kouba M.; Lopez Puente S.; Lopez-Alonso M.; Nielsen S.S.; Pechova A.; Petkova M.; Girault S.; Broglia A.; Guerra B.; Innocenti M.L.; Liebana E.; Lopez-Galvez G.; Manini P.; Stella P.; Peixe L.. - In: EFSA JOURNAL. - ISSN 1831-4732. - ELETTRONICO. - 19:10(2021), pp. e06856.1-e06856.22. [10.2903/j.efsa.2021.6856]
Koutsoumanis K.; Allende A.; Alvarez-Ordonez A.; Bolton D.; Bover-Cid S.; Chemaly M.; Davies R.; De Cesare A.; Herman L.; Hilbert F.; Lindqvist R.; Nauta M.; Ru G.; Simmons M.; Skandamis P.; Suffredini E.; Andersson D.I.; Bampidis V.; Bengtsson-Palme J.; Bouchard D.; Ferran A.; Kouba M.; Lopez Puente S.; Lopez-Alonso M.; Nielsen S.S.; Pechova A.; Petkova M.; Girault S.; Broglia A.; Guerra B.; Innocenti M.L.; Liebana E.; Lopez-Galvez G.; Manini P.; Stella P.; Peixe L.
File in questo prodotto:
File Dimensione Formato  
EFSA antimicrobials part 5.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non opere derivate (CCBYND)
Dimensione 2.2 MB
Formato Adobe PDF
2.2 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/883835
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 4
social impact